EDWARD LUSCHINSKI: Open Payments
NPI 1205447448 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$918 in 44 payments from 12 companies in 2025. Trend: 2023 $965 · 2024 $735 · 2025 $918
Food & beverage: $918
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 11 | $226 |
| Averitas Pharma Inc. | 6 | $170 |
| Collegium Pharmaceutical, Inc. | 7 | $130 |
| ABBVIE INC. | 4 | $85 |
| Medtronic, Inc. | 4 | $72 |
| PFIZER INC. | 3 | $51 |
| Amgen Inc. | 2 | $37 |
| Valinor Pharma, LLC | 2 | $36 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $32 |
| INTERNATIONAL REHABILITATIVE SCIENCES, INC | 1 | $29 |
Products named: WaveWriter Alpha Prime 16, QUTENZA, Belbuca, QULIPTA, NURTEC ODT, Intracept, SYNCHROMEDII, KRYSTEXXA.
Industry payments across MD — which companies pay providers there.
